Literature DB >> 19841578

Thymus microenvironment in human primary immunodeficiency diseases.

Pietro Luigi Poliani1, William Vermi, Fabio Facchetti.   

Abstract

PURPOSE OF REVIEW: Severe combined immunodeficiencies represent a heterogeneous group of genetic disorders affecting genes of both early and late steps in lymphocytes development, a process tightly controlled by thymic epithelial cells. Detailed analysis of thymic morphology aids to the assessment of the severity of the immune disorder and may be critical to the understanding of the role of the genetic defects in the pathophysiology of these diseases. In this review, we highlight recent advancements in the characterization of the thymic microenvironment in primary immunodeficiencies. RECENT
FINDINGS: Crosstalk between thymocytes and thymic epithelial cells is essential to preserve thymic architecture and function, and therefore to promote T-cell maturation and development of self-tolerance. Early severe defects in T-cell development result in profound abnormalities of thymic epithelial cells differentiation with loss of AIRE expression and severe reduction of thymic dendritic and T-regulatory cells. Differently, later defects in T-cell development that are permissive for normal thymocytes development allow cortico-medullary differentiation with partially preserved AIRE expression and dendritic/T-regulatory cells distribution. Hypomorphic mutations in the same genes partially permissive to T-cell development may result in a more complex phenotype with immunodysreactivity and peculiar thymic alterations.
SUMMARY: Although the molecular and genetic bases of primary immunodeficiencies directly aid to both diagnosis and management of the patients, the detailed analysis of thymic morphology critically contributes to unveil the pathophysiology of these diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841578     DOI: 10.1097/ACI.0b013e3283327e5c

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  14 in total

1.  Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications.

Authors:  Veronica Marrella; Pietro L Poliani; Elena Fontana; Anna Casati; Virginia Maina; Barbara Cassani; Francesca Ficara; Manuela Cominelli; Francesca Schena; Marianna Paulis; Elisabetta Traggiai; Paolo Vezzoni; Fabio Grassi; Anna Villa
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

Review 2.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 3.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

4.  Hypomorphic Rag mutations can cause destructive midline granulomatous disease.

Authors:  Suk See De Ravin; Edward W Cowen; Kol A Zarember; Narda L Whiting-Theobald; Douglas B Kuhns; Netanya G Sandler; Daniel C Douek; Stefania Pittaluga; Pietro L Poliani; Yu Nee Lee; Luigi D Notarangelo; Lei Wang; Frederick W Alt; Elizabeth M Kang; Joshua D Milner; Julie E Niemela; Mary Fontana-Penn; Sara H Sinal; Harry L Malech
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

Review 5.  Genetics of SCID.

Authors:  Fausto Cossu
Journal:  Ital J Pediatr       Date:  2010-11-15       Impact factor: 2.638

6.  PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.

Authors:  Anne-Laure Mathieu; Estelle Verronese; Gillian I Rice; Fanny Fouyssac; Yves Bertrand; Capucine Picard; Marie Chansel; Jolan E Walter; Luigi D Notarangelo; Manish J Butte; Kari Christine Nadeau; Krisztian Csomos; David J Chen; Karin Chen; Ana Delgado; Chantal Rigal; Christine Bardin; Catharina Schuetz; Despina Moshous; Héloïse Reumaux; François Plenat; Alice Phan; Marie-Thérèse Zabot; Brigitte Balme; Sébastien Viel; Jacques Bienvenu; Pierre Cochat; Mirjam van der Burg; Christophe Caux; E Helen Kemp; Isabelle Rouvet; Christophe Malcus; Jean-Francois Méritet; Annick Lim; Yanick J Crow; Nicole Fabien; Christine Ménétrier-Caux; Jean-Pierre De Villartay; Thierry Walzer; Alexandre Belot
Journal:  J Allergy Clin Immunol       Date:  2015-04-02       Impact factor: 10.793

7.  Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.

Authors:  Aisha Vanessa Sauer; Immacolata Brigida; Nicola Carriglio; Alessandro Aiuti
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

8.  Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies.

Authors:  Roshini S Abraham
Journal:  Clin Mol Allergy       Date:  2011-04-09

9.  Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus.

Authors:  Vineet Kumar Khemka; Debajit Bagchi; Arindam Ghosh; Oishimaya Sen; Aritri Bir; Sasanka Chakrabarti; Anindita Banerjee
Journal:  ScientificWorldJournal       Date:  2013-12-25

Review 10.  Expression of the autoimmune regulator gene and its relevance to the mechanisms of central and peripheral tolerance.

Authors:  Roberto Perniola
Journal:  Clin Dev Immunol       Date:  2012-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.